CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease
-
3 2022
-
-
Source: Am J Prev Med. 62(3):e202-e222
[PDF-542.70 KB]
Details:
-
Alternative Title:Am J Prev Med
-
Personal Author:
-
Corporate Authors:
-
Description:Introduction:
Adherence to medications for cardiovascular disease (CVD) and its risk factors is less than optimal though greater adherence to medication has been shown to reduce the risk factors for CVD. This paper examines the economics of tailored pharmacy interventions to improve medication adherence for CVD prevention and management.
Methods:
Literature from inception of databases to May 2019 was searched, yielding 29 studies for CVD prevention and 9 studies for CVD management. Analyses were done from June 2019 through May 2020. All monetary values are in 2019 U.S. dollars.
Results:
The median intervention cost per patient per year was $246 for CVD prevention and $292 for CVD management. The median change in healthcare cost per person per year because of the intervention was −$355 for CVD prevention and −$2,430 for CVD management. The median total cost per person per year was −$89 for CVD prevention, with a median return on investment of 0.01. The median total cost per person per year for CVD management was −$1,080, with a median return on investment of 7.52 and 6 of 7 estimates indicating reduced healthcare cost averted exceeded intervention cost. For CVD prevention, the median cost per quality-adjusted life year gained was $11,298. There were no cost-effectiveness studies for CVD management.
Discussion:
The evidence shows tailored pharmacy-based interventions to improve medication adherence are cost effective for CVD prevention. For CVD management, healthcare cost averted exceeds the cost of implementation for a favorable return on investment from a healthcare systems perspective.
-
Subjects:
-
Source:
-
Pubmed ID:34876318
-
Pubmed Central ID:PMC8863641
-
Document Type:
-
Funding:
-
Volume:62
-
Issue:3
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
